Osimertinib-induced keratitis and secondary toxic epidermal necrotic drug eruption- A case report and literature review
CONCLUSION: Although the clinical use of osimertinib is becoming widespread, the side effects may not be fully understood. Clinicians should pay more attention to the occurrence of the side reaction and deal with it in time.PMID:37254553 | DOI:10.2174/1574886318666230529123200
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Yunhua Xu Yong Li Jie Luo Rong Tang Source Type: research
More News: Adenocarcinoma | Brain | Brain Cancers | Cancer | Cancer & Oncology | Drugs & Pharmacology | Epidermolysis Bullosa | Genetics | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Toxicology